{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:40:48Z","timestamp":1784644848381,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jocn.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T19:15:13Z","timestamp":1398539713000},"page":"1575-1578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Elevation of serum lactate dehydrogenase at posterior reversible encephalopathy syndrome onset in chemotherapy-treated cancer patients"],"prefix":"10.1016","volume":"21","author":[{"given":"Ryan T.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan S.","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu H.","family":"Ramakrishnaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Van Hemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo J.","family":"Angtuaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2014.03.004_b0005","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2014.03.004_b0010","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0024-3205(00)00554-3","article-title":"Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus","volume":"66","author":"Kochi","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2014.03.004_b0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"Pickering","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2014.03.004_b0020","doi-asserted-by":"crossref","first-page":"468.e1","DOI":"10.1016\/j.ajog.2013.02.015","article-title":"Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia","volume":"208","author":"Brewer","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jocn.2014.03.004_b0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0095-5108(18)30490-1","article-title":"Pathophysiology of preeclampsia","volume":"18","author":"Friedman","year":"1991","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.jocn.2014.03.004_b0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1538-7836.2008.03259.x","article-title":"Vascular biology of preeclampsia","volume":"7","author":"Myatt","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jocn.2014.03.004_b0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3174\/ajnr.A0839","article-title":"Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2014.03.004_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2012-10-462135","article-title":"Lactate dehydrogenase and hemolysis in sickle cell disease","volume":"121","author":"Ballas","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jocn.2014.03.004_b0045","first-page":"570","article-title":"Serum lactate dehydrogenase as early marker of posterior reversible encephalopathy syndrome: keep your eyes open","volume":"40","author":"Vargas","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jocn.2014.03.004_b0050","first-page":"569","article-title":"The clinical value of lactate dehydrogenase in serum: a quantitative review","volume":"35","author":"Huijgen","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jocn.2014.03.004_b0055","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jocn.2014.03.004_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0609.2010.01466.x","article-title":"High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents","volume":"85","author":"Terpos","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jocn.2014.03.004_b0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2007-994482","article-title":"Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death","volume":"12","author":"Catanzarite","year":"1995","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jocn.2014.03.004_b0070","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/cncr.25631","article-title":"Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma","volume":"117","author":"Eigentler","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.03.004_b0075","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/j.ijrobp.2011.06.1967","article-title":"Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis","volume":"82","author":"Zhou","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2014.03.004_b0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.rct.0000233127.21303.b9","article-title":"\u201cRecurrent\u201d posterior reversible encephalopathy syndrome: report of 3 cases\u2013PRES can strike twice!","volume":"31","author":"Sweany","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jocn.2014.03.004_b0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2214\/ajr.165.3.7645483","article-title":"Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases","volume":"165","author":"Schwartz","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocn.2014.03.004_b0090","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.ejrad.2011.12.010","article-title":"Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience","volume":"81","author":"Goa","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jocn.2014.03.004_b0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s13760-012-0060-y","article-title":"Relationships between edema degree and clinical and biochemical parameters in posterior reversible encephalopathy syndrome: a preliminary study","volume":"112","author":"Bo","year":"2012","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jocn.2014.03.004_b0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.WNL.0000042095.49520.1E","article-title":"Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm","volume":"60","author":"Henderson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.03.004_b0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.20147","article-title":"Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies","volume":"77","author":"Tam","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jocn.2014.03.004_b0110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2014.03.004_b0115","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00415-013-6866-6","article-title":"Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with bevacizumab, gemcitabine and cisplatin","volume":"260","author":"Dersch","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2014.03.004_b0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/1752-1947-6-409","article-title":"Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: a case report","volume":"6","author":"Zahir","year":"2012","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jocn.2014.03.004_b0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3109\/10428194.2011.638070","article-title":"Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide","volume":"53","author":"Chow","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jocn.2014.03.004_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RCT.0b013e3181f31917","article-title":"Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy","volume":"35","author":"Kofler","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jocn.2014.03.004_b0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3174\/ajnr.A1311","article-title":"Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression","volume":"30","author":"Horbinski","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2014.03.004_b0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/qjmed\/hcr139","article-title":"Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment","volume":"105","author":"Seet","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.jocn.2014.03.004_b0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12029-011-9279-8","article-title":"Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma","volume":"43","author":"Chang","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.jocn.2014.03.004_b0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11523-011-0201-x","article-title":"Posterior reversible encephalopathy syndrome induced by anti-VEGF agents","volume":"6","author":"Tlemsani","year":"2011","journal-title":"Target Oncol"},{"key":"10.1016\/j.jocn.2014.03.004_b0155","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1200\/JCO.2006.08.4608","article-title":"Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43\u20139006","volume":"24","author":"Govindarajan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2014.03.004_b0160","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/annonc\/mdm454","article-title":"Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome","volume":"18","author":"Kapiteijn","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2014.03.004_b0165","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/JTO.0b013e3181e2f7fb","article-title":"A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung","volume":"5","author":"Leighl","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jocn.2014.03.004_b0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000324581","article-title":"Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome","volume":"4","author":"Marrone","year":"2011","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jocn.2014.03.004_b0175","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/10428190600581815","article-title":"A rare complication in a case of multiple myeloma on therapy with thalidomide and dexamethasone\u2014reversible posterior lobe leukoencephalopathy","volume":"47","author":"Pandey","year":"2006","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T06:12:35Z","timestamp":1716703955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0967586814001118"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2014.03.004","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevation of serum lactate dehydrogenase at posterior reversible encephalopathy syndrome onset in chemotherapy-treated cancer patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}